At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 23, 2026 at 08:30 ET
Bicara Therapeutics announced it will report its Q4 and full-year 2025 financial results on March 30, 2026, along with a business update. The company will host a conference call to discuss the results, but no financial data or material updates were released in this press release.
- Bicara Therapeutics will report Q4 and full-year 2025 financial results on March 30, 2026, before market open.
- A conference call is scheduled for 8:30 a.m. ET on the same day to discuss results and business updates.
- No financial figures, guidance, or material operational updates were disclosed in this announcement.
- The company remains in clinical-stage development with ficerafusp alfa as its lead asset.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access